Robotic Bronchoscopy for Lung Nodules

(SERENE Trial)

This trial aims to determine which robotic bronchoscopy method better diagnoses lung nodules. It compares two systems: the Ion™ Endoluminal System, which uses shape-sensing technology, and the Galaxy system by Noah Medical, which uses electromagnetic navigation. Patients scheduled for a bronchoscopy to evaluate lung lesions (abnormal tissue growths) may qualify for the trial. The goal is to identify which system provides a more accurate diagnosis. As an unphased trial, this study allows patients to contribute to advancements in medical technology and improve diagnostic methods for future patients.

The trial information does not specify whether you need to stop taking your current medications.

Research has shown that both the Ion™ Endoluminal System and the Galaxy System are generally safe based on previous studies.

For the Ion™ Endoluminal System, one study examined 155 patients and found it allows for accurate biopsies while remaining safe. The study identified no major safety issues, suggesting the procedure is usually well-tolerated.

Similarly, trials with 31 patients tested the Galaxy System, which also demonstrated a strong safety record. No major problems were reported, indicating it is well-tolerated. Additionally, the FDA approved the Galaxy System in 2023, confirming it meets certain safety standards for its intended use.

Researchers are excited about the robotic bronchoscopy techniques being explored because they offer a more precise and less invasive way to diagnose lung nodules compared to traditional methods. The Ion™ Endoluminal System uses advanced shape-sensing technology that allows doctors to navigate the complex pathways of the lungs with greater accuracy. Meanwhile, the Galaxy by Noah employs electromagnetic navigation, providing real-time guidance to reach nodules effectively. These innovations could lead to quicker, more accurate diagnoses, potentially improving patient outcomes and reducing the need for more invasive procedures like surgical biopsies.

This trial will compare two robotic bronchoscopy systems for diagnosing lung nodules. Research has shown that the Ion Endoluminal System, one of the systems tested in this trial, helps doctors accurately reach and sample small lung nodules, effectively identifying cancerous tissues. The Galaxy system, another system under study, demonstrated a 100% success rate in procedures for patients with lung nodules, showcasing its ability to navigate and perform biopsies. Both systems offer new ways to access difficult areas in the lungs, improving the chances of early and accurate diagnosis. These advancements could lead to better outcomes for patients with lung nodules.⁶⁷⁸⁹¹⁰